1 / 66

Unit 6

Unit 6. Gordons Functional Health Pattern Activity - Exercise. Blood Disorders. Blood Conditions. Unit objectives: Discuss the components, characteristics and functions of the hematopoietic system. Compare the assessment data and the pathophysiologic bases that occurs in blood disorders

gus
Download Presentation

Unit 6

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Unit 6 Gordons Functional Health Pattern Activity - Exercise Blood Disorders

  2. Blood Conditions • Unit objectives: • Discuss the components, characteristics and functions of the hematopoietic system. • Compare the assessment data and the pathophysiologic bases that occurs in blood disorders • Discuss blood transfusion administration, reactions and management • Describe the various anemia’s in relationship to decreased, increased and hemolysis of erythrocytes • Discuss diagnostic tests, medical management and nursing interventions for the anemia

  3. Blood conditions • Discuss the chronic conditions in which anemia can occur. • Describe sickle cell crisis and its management • Differentiate between DIC and clotting problems • Compare and contrast acute (ALL, ANLL) and chronic (CML, CLL) leukemias, their clinical manifestations and management. • Compare and contrast lymphomas, multiple myeloma, Hodgkin’s and non-Hodgkin’s lymphoma, their diagnostic evaluations, clinical manifestations and management. • Discuss other FHP’s that might relate to hematopoietic problems

  4. Blood Conditions REQUIRED READING: • Smeltzer: Chapter 33

  5. Blood Conditions • A & P review: blood • Hematologic system  blood, bone marrow & reticuloendotheliaL system [REM] • Organs: Peripheral Lymphoid Tissue – sites for antigen processing • Lymph nodes- small organs, < 5 mm in diameter, found throughout body & interconnected w lymph vessels; provide RES & immune functions; receive fluids taken up by lymphatic capillaries from distal tissue sites. Macrophages w/I the node monitor the fluid for foreign particulates & phagocitis them; found in large numbers in abdominal & thoracic areas; called superficial nodes – lying close to the body surface; when inflamed & swollen  palpated & diagnostic • Lymph nodules – modules found in mucosal epithelium lining in resp, GI, and urogenital tracts.

  6. Blood conditions • Central Lymphoid Organs • Spleen – largest lymphoid organ in body; functions  blood-clearing process; assisting in recycling iron by capturing HgB released from destroyed RBC’s, and removing particles from RBC’S w/o destroying the cell itself; the pulp is divided into red zones & white zones ( accumulations of lymphocytes) • Thymus – located in the mediastinum, reaches peak development during childhood; endocrine organ secretes hormones that contributes to maintenance of T-cells.

  7. Blood conditions • Bone marrow – one of largest organs in body, total weight in adult of about 3000 g (comparable to liver); • Visual appearance –red marrow – hematopoietic cells interspaced w sinusoidal capillaries and yellow marrow – large number of adipose cells • Functions: • Stem cells – primitive; self-replicate, all blood cells are derived • An environment for the differentiation and maturation of blood cells • A storage site for large numbers of neutrophils & erythrocytes • Transformation of undifferentiated lymphocytes into mature Hematopoiesis

  8. Blood conditions • Blood  mixture of cells- RBC’s, WBC’s, & platelets, plasma • Functions: supplies oxygen from the lungs & absorbed nutrition from the GI tract to cells’ • Removing waste products from tissues to the kidneys, skin & lungs for excretion • Transporting hormones from their origin in the endocrine glands to other areas of body • Protecting the body from dangerous microorganisms • Promoting homeostasis ( the arrest of bleeding) • Regulating body temperature by heat transfer

  9. Composition of blood • 8% of total body wt is blood; young female has 4-5 L, young male has 5-6 L • Inverse relationship between blood volume & kg of body wt  the less body fat, the more blood per kg of body wt • Arterial blood is bright red because of O2 bound to Hgb & w/I RBC’s. venous blood is darker • Blood is 3-4x more viscous [thick] than water. • Blood is slightly alkaline, pH of 7.35 -745 [neutral pH is 7.0]

  10. Plasma • The liquid portion of the blood, • 55% of blood • 92% water, 7% protein, and < 1% nutrients, metabolic wastes, resp gases, enzymes, hormones, clotting factors, • 45% suspended particles [blood cells & platelets] • Major function is to maintain blood volume • Packed cell volume or hematocrit: the volume or % of the RBC’s in sample –35% to 45% • HcT can be  from loss of plasma (dehydration) or  production of RBC’s (polycythemia) • WBC’s & platelets -1 % of blood volume; form a buff coat or white layer seen at interface of the RBC’s and plasma

  11. RBC’s • Erythrocytes • carry O2 or hemoglobin to the cells & CO 2 back to lungs • Assist with acid-base balance – carbonic anhydrase • Structure: no nucleus, 7.5 um in diameter, depression on flat side  very large surface area, to allow cell to change shape passively as it goes thru capillaries. • Production  erythropoises every minute, more than 100 million RBC’ s are formed to replace of destroyed cells. • Precursor cells, proper microenvironment, & adequate supplies of iron, vit B12, folic acid, protein, pyridoxine & traces of copper • Arise from nucleated cells called hematopoietic stem cells • Immature erythrocytes leave the bone marrow  circulation now called reticulocytes  spleen  undergo conditioning  mature erythrocytes  general circ. Life span 105-120 days •  RBC production when O2 levels ↓ ; during pregnancy or erythropoietin – healthy bone marrow can increase production 6-7 x normal rate

  12. RBC’s • Erythrocytes • Aged erythrocytes  fragile  rupture  release of hemoglobin, “ghost cells”, taken up by macrophages  hemoglobin broken down into heme (iron) goes to liver; porphyrin  liver converts into bilirubin  excreted as bile • Nutritional influences on RBC production • Vit B12 – RBC maturation, nervous system function • Not synthesized in body, must ingest from diet [meat, dairy products]; called extrinsic factor (outside the body), when digested from food, Vit B 12 binds w glycoprotein called intrinsic factor (inside body) in duodenum for absorption in the blood • Folic acid – a B-group vit, • Synthesized by many plants & bacteria; food sources: vegetables & fruit • Iron – essential to hemoglobin production. • Adults 50 mg of Fe per 100 ml of blood; Hgb accounts for 2/3 of iron (essential iron), 1/3 resides in bone marrow, spleen & liver. In Fe deficiency develops these stores are reduced first, followed by a gradual loss in Hgb

  13. Platelets • Platelets (thrombocytes) • Are granular fragments from giant multinucleated cells in red bone marrow (megakaryocytes); takes 5 days to form & live only 7 -10 days • have two roles in homeostasis: • Occlusion of small openings in blood vessels • Provide chemical components leading to coagulation • Substances released from platelet aggregation activate coag factors that provide for a stable clot or plug w fibrin

  14. Role of liver & spleen • Spleen – reservoir for erythrocytes – during severe anemia • Liver – fixed macrophages (Kupffer cells) remove inanimate particulates & bacterial cells; • Production of small quantities of erythropoietin • Synthesis of plasma proteins & clotting factors • Decomposition of Hgb into bilirubin • Storage of iron in form of ferritin

  15. Homeostasis • Normal homeostasis – process that repairs vascular breaks to reduce blood loss while maintaining the flow of blood through vascular system; 3 components: • Blood vessels, the platelets, & coagulation factors • Work in 3 stages: • Vascular phase  vasoconstriction of the vessel occurs • Blood vessels supplying the site constrict (muscular tissue & reflex nervous system reactions, serotonin is released. • Formation of a platelet plug • In circulation, recognize a disruption or alteration in the endothelial lining of blood vessels  become sticky & adhere to one another • Coagulation or formation of a fibrin clot • If bleeding is severe, coagulation factors must join w platelets for form a permanent clot • once clot has served its purpose, it is balanced by fibrinolysis (clot dissolution)

  16. Homeostasis • Clot formation: results in either one or two pathways: table 1, pg 63 a • Extrinsic pathway: initiated when tissue injury occurs outside the vessel i.e.: burn • Damaged tissue releases factor III (tissue thromboplastin) which initiates the clotting cascade to form activated factor X  leads to clot formation • Intrinsic pathway: involves blood itself, i.e.: antigen – antibody reactions & endotoxins; • All factors for this reaction already in blood; pathway starts when factor VII is exposed to a foreign surface  cascade of enzymatic reactions to activate factor X • Activated Factor X is responsible for conversion of prothrombin to thrombin & soluble fibrinogen to insoluble fibrin clot (forms dense interlacing threads to entrap cells)

  17. Fibrinolysis • Blood carries natural anticoagulants – heparin, antithrombin • Clot dissolves: • Plasminogen is required to breakdown fibrin, already in blood & in clot  turns into plasmin  digests the fibrinogen & fibrin

  18. Leukocytes (WBC’s) • 5 types _classified according to presence or absence of granules & staining characteristics of their cytoplasm • Myeloid Stem cell  granulocytes 3 types: • Neutrophils – primary cell to respond to an acute inflammatory response, stored primarily in bone marrow • Eosinophils – protect against parasitic infections & modulate IgE – mediated allergic responses. • Basophils – store heparin, histamine • Agranulocytes (WBC w/o cytoplasmic granules) 2 types: • Monocyte – released into circ as a immature phagocytic cell,  liver, transform into macrophage with full phagocytic function • Lymphocytes – some programmed to become T cells & others B cells in bone marrow • B cells function in antibody-mediated immune response to defend the body against invasive types of bacteria,, bacterial toxins & some virus • T cells are bases of cell-mediated immune functions that defend against intracellular pathogens, fungi & virus

  19. Anemia’s • Loss of RBCs • Decreased production of RBCs • Increased destruction of RBCs • Medical management is directed towards correcting or controlling the cause and/or replacement of RBCs • Nursing interventions are directed at managing fatigue, maintaining adequate nutrition and perfusion, complying with prescribed therapy, and monitoring and managing potential complications

  20. Types of Anemia • Anemias of Renal Disease and Chronic Disease • Aplastic • Iron Deficiency • Megaloblastic • Myelodysplastic Syndromes • Hereditary Hemochromatosis • Thalassemia • Sickle Cell • Immune Hemolytic

  21. Anemias 2. Anemia in renal dz – due to decreased production; deficiency of erythropoietin and shortened RBC life span 3. Anemia in chronic disease – due to decreased production, deficiency of erythropoietin and shorten RBC life span 4. Iron-deficiency anemia (chronic, microcytic, hypochromic) a. Pathophysiology – inadequate absorption or excessive loss of iron b. clinical manifestations Lab – low hbg, ↓total RBC, MCV, MCH & MCHC. Mild case may be asymptomatic c. Management/nursing determine cause, iron preparations, diet, preventive education – diet with foods high in iron – organ meats, beans, leafy vegetables, raisins, molasses. Pace/plan activities. 5. Magablastic anemia – caused by deficiencies of vitamin B12 and or folic acid.

  22. Anemias • Aplastic anemia (normochromic normocytic) pancytopenia ↓ RBC,WBC,and Platelets • Pathophysiology – decrease in or damage to marrow stem cells. • Clinical manifestation Lab:↓RBC gradual onset, weakness, dyspnea on exertion, abnormal bleeding when thrombocytopenia present. • Management/nursing bone marrow transplantation, immunosuppressivetherapy, supportive therapy (transfusions), preventive education. Plan/pace activities and avoid trauma.

  23. Anemias 6. Vitamin B12 deficiency (pernicious anemia) • Pathophysiology – faulty absorption from the GI tract, lack of intrinsic factor • Clinical Manifestations Lab - ↓ RBC, WBC, and MCH and  MCV and number of megaloblasts (by bone marrow aspiration). Schilling test SXS – pale, fatigue, weakness, smooth sore red tongue, mild diarrhea, confusion, paresthesia of extremities, difficulty maintaining balance. • Management/nursing preventive education – vegetarians vit B12 administration support during tests care of neuropathy problems • Folic acid deficiency – more commonly seen than Vit deficiency a. Pathophysiology – folic acid deficiency b. Clinical manifestations – Lab – decreased serum folate – schilling test. Sxs – sore red tongue, no neurological manifestations c. Management/Nursing diet – uncooked vegetables, green leafy vegetable, liver, citrus fruits, and yeast folic acid supplementations.

  24. Anemias Hemolytic anemias: • Major hallmarks – shortened RBC life span, abnormal increase in the number of RBC destroyed and failure of the bone marrow to replace destroyed RBCs • Causes trauma, chemical agents and medications, infectious agents, systemic disease, antigen-antibody reactions • Clinical manifestations Lab:  retic count,  indirect bilirubin, ↓haptoglobuin and red cell survival study. SXS – pale, dyspnea, jaundice, cholelithiasis, splenomegaly, hepatomegaly • Management/nursing ID cause and correct maintain fluid and electrolytes balance 02 administrations, preventive education, pace/plan activities

  25. Anemias Inherited hemolytic anemias • Herditary spherocytosis (congenital hemolytic jaundice, congenital sphereocytic anemia). Inherited as a simple medelian dominant trait a. clinical manifestations – anemia, jaundice, splenomegaly b. Management/nursing – splenectomy, O2 adm, blood transfusion • Sickle Cell anemia a. Pathophysiology – inheritance of the sickle hemoglobin gene (Hbs) b. Clinical manifestations – anemia, jaundice. c. preventive education – avoid infections, cold temps. supportive care – hydration, avoid high attitudes, folic acid d. Sickle Cell Crisis – (occlusion of microcirculation) clinical manifestations – severe pain, fever, and leukocytosis management/nursing – control of pain, IV fluids, transfusions, O2 therapy.

  26. Anemias 3. Thalassemia (Mediterranean anemia, cooley’s anemia) Characteristics – hypochromia, microcytosis, hemolysis, variable degrees of anemia • Classified (according to affected globin chain) • a-thalassemia – mild form • b-thalassemia – more common form • Thalassemia minor – asymptomatic • Thalassemia major (cooley’s anemia) – severe anemia, marked hemolysis of erythorytes, jaundice. TX – splenomegaly, transfusions.

  27. Anemias 4. Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD) • Pathophysiology – a genetic defect of the RBC • Clinical manifestations Lab – G6PD may be asymptomatic, jaundiced, pallor, increased reticulocyte, Heins bodies • Management/Nursing – preventive education, rest, fluids & nutritious diet, transfusions 5. Acquired Hemolytic Anemias Immune hemolytic anemia as a result from exposure of the RBC to antibodies. a. Clinical manifestation – fatigue, dyspnea, jaundice, splenomegaly b. Management/nursing – ID causative agent, corticosteroids, blood transfusions, spleenectomy, immunosuppressive agents.

  28. Polycythemia • Polycythemia Vera is a proliferative disorder in which myeloid stem cells escape normal control mechanisms • RBC, WBC, and platelet counts are elevated • Secondary Polycythemia is caused by excessive production of erythropoietin • May occur as response to hypoxia or neoplasms • Medical management is removal of cause or therapeutic phlebotomy

  29. Leukopenia and Neutropenia • Leukopenia is condition of fewer WBCs than normal, results from neutropenia or lymphopenia • Neutropenia results from decreased production or increased destruction of neutrophils • Medical management varies depending on cause • Nursing management is towards preventing and managing infections

  30. Leukocytosis and Leukemias • Leukocytosis is an increased level of WBCs • Leukemia is a neoplastic proliferation of one particular cell • Acute and Chronic Myeloid Leukemia • Acute and Chronic Lymphocytic Leukemia • Agnogenic Myeloid Metaplasia

  31. Leukemia • Is a malignant ds of the blood-forming organs. • 8% of all human cancers • Most common in children & young adults – 80% are lymphatic; 20% nonlymphatic; adults are opposite • Cause unknown • Risk factors: genetic factors; exposure to ionizing radiation & chemicals (benzene); medications ( alkylating agents); congenital abnormalities (Down’s syndrome); presence & infection w human T-cell leukemia virus type 1 [HTLV-1]

  32. Leukemia • Pathophysiology: uncontrolled proliferation of leukocytes  lack of control  normal bone marrow to be replaced by immature & undifferentiated leukocytes (blast cells)  circulate in blood & infiltrate blood forming organs (liver spleen, lymph nodes) • Classification: acute leukemia's are classified according to their morphologic characteristics & histo-chemical staining of blast cells  indicates the % of immature cells in bone marrow

  33. Acute leukemia • Acute = 50% of the marrow cells must be immature; two major forms: lymphocytic & nonlymphocytic leukemia • Clonal disorders  a single lymphocyte stem cell undergoes transformation  divide slowly & take longer to synthesize DNA (blast phase leaving WBC’s undifferentiated or blasts  block cell precursors & compete w normal cellular proliferation “blocking out” the marrow & cause other cell lines to stop production  causing pancytopenia ( a reduction in all cellular components) • Acute lymphoblastic leukemia (ALL) • Most common in children (median age 11 yrs), acute course—initial symptoms & w/o tx die 3-6 months, males > females, more common in European – Americans

  34. Acute Leukemia • Acute adult nonlymphatic leukemia (AANLL) – more common in adults, (median age 67 yrs), also called acute myeloid leukemia (AML) • involves the rapid accumulation of hematopoietic stem cells, (differentiate into monocytes, granulocytes, RBC’s, and platelets) • History: questions – exposure to radiation, chemicals, viruses, & medications, occupation? Power plant or serving in military • S&S: sudden onset of high fever, signs of abnormal bleeding [bleeding gums, long menses, petechiae,  bruising, nose bleeds],  fatigue & malaise, wt loss, night sweats & chills, c/o abd or bone pain, appear acutely ill, dyspnic, & pale, enlarged liver &lymph nodes; CNS involvement – HA, vomiting & papilledema, blurred vision, meningeal irritation, intracranial hemorrhage,  chemo does not pass the blood brain barrier • psychosocial assessment  pts, families are shocked & fearful

  35. Acute leukemia • Neutropenic precautions- neutrophils < 2000 mm3, necessary in prevention & limiting infections (chart 33-9, page 898) • Bone marrow transplant – BMT is the administration of 500-700 ml of marrow aspirated from the pelvic bones of the patient during a remission (autologous transplant) – most common; (allogeneic transplant) – compatible donor – usually a parent or sibling. • Transfusion of RBC’s & platelets – may be required until the BM produces mature cells • Radiation TX – adjunct to chemo when leukemic cells infiltrate the CNS, skin, large mediastinal mass

  36. Chronic Leukemia • Chronic lymphatic leukemia (CLL) –involves lymphocytes, (cells that circulate among the blood, lymph nodes, lymphatic & lymphoid organs); characterized by an uncontrollable spread of abnormal, small lymphocytes (early B lymphocytes) • 33% of new leukemia cases annually in US are dx as CLL. • Least malignant form & progresses more slowly than others, sometimes takes as long as 15 yrs (WBC produced are more mature & better to defend body against infection)

  37. Chronic Leukemia • Causes: unknown, several risk factors:  families, suggesting heredity issues, possible genetic predisposition, immunologic defects – ataxia-telangiectasia (vascular lesions formed by dilation of a group of small vessels, birthmarks) • Men > woman, and over the age of 50 • S&S: same as all types of leukemia;  anemia, thrombocytopenia, & leucopenia; hx of malaise & enlarged nodes, fever  susceptible to opportunistic fungal, viral & bacterial infections, lost wt, any bleeding, family hx of CLL, pale, enlarged liver or spleen, skin has macular or nodular infiltrates

  38. Chronic Leukemia • Chronic myelogenous leukemia or chronic granulocytic leukemia – characterized by abnormal overgrowth of myeloblasts (all granulocytic precursors) • Gradual onset, WBC’s more mature • Two phases: insidious chronic phase – originates in the pluripotent stem cell w an initial finding of hyper cellular marrow w a majority of normal cells; after approx 4 yrs.  enters a blast crises or acute phase. • Causes: 90% of pts have the abnormal Philadelphia chromosome – thought to be induced by radiation or carcinogenic chemicals; unidentified virus • Occurs more commonly in young-to middle aged adults; 25 -60 yrs of age; slightly more men than women

  39. The Lymphomas • Neoplasms of cells of lymphoid origin • Hodgkin’s Disease • Non-Hodgkin’s Disease • Multiple Myeloma

  40. Lymphoma’s • Originating from the lymphatic system, lymphoma is most common tumor of lymphoid system; primary (thymus or BM) or secondary tissue ( lymph nodes, spleen, tonsils)-most arise from secondary • Major subdivisions are: Hodgkin’s lymphoma / Hodgkin's Disease (HD); Non – Hodgkin’s lymphoma (NHL) • 55,000 cases dx annually

  41. Hodgkin’s Disease • In 1832, Hodgkin described a ds w enlarged lymph nodes starting in the neck & spreading throughout the body & bx showed a distinctive large cell – called the Reed-Sternberg cell – when the cell is absent the ds is classified as NHL • Incidence – 7500 new cases per yr, slightly more males than females, strikes in young adult hood (ages 15 to 38) & a second peak later in life > 50, worse prognosis • Etiology – exact cause unknown, researchers suspect an infectious component, ie: Epstein-Barr virus (organ transplant recipients/ immunodeficiency ds, hx of mononucleosis (2-3x), some studies show genetic predisposition (Jews)

  42. Hodgkin’s Disease • Pathophysiology – painless progressive enlargement of LN, caused by a proliferation of lymphocytes, histiocytes, eosinophils & Reed – Sternberg giant cells. • Progressive & fatal if not treated, but one of the most curable w tx (5yr survival rate > 90%) • S &S- often are asymptomatic & present w painless lymphadenopathy – • . Nonproductive cough –X-ray shows a mediastinal mass in 50% of pts; • freq noc sweats & fever > 38 *C • Dx: LN & bone marrow bx, Chest - X-ray; CT of thoracic, abd & pelvis & staging laparotomy

  43. Hodgkin’s Disease • Staging: HD is divided into stages according to the microscopic appearance of involved LN, the extent & severity & prognosis

  44. Hodgkin’s Disease • Tx- begins w accurate classification & staging • Radiation is used for early less extensive ds • Stage 2 is combination of radiation & chemo used for IIB, and III A & B, • combo chemo for stage 4

  45. Non-Hodgkin’s Lymphoma • AKA – malignant lymphoma; comprises a group of malignancies w a common origin in the lymphoid cells’ characterized by random proliferation of lymphocytes • Ranges from aggressive, rapidly fatal to indolent nodular varieties • Less promising prognosis than HD • ACS – estimates 55,000 new cases annually, & 25,000 related deaths; average age at dx is in 50’s • 7 x more common than HD • Between 1973 & 1992, a 75% increase in NHL • 60 X more common in pts w AIDS • 6th most common cause of cancer • Men > woman;  in whites than other races

  46. Non-Hodgkin’s Lymphoma • Pathophysiology – an abnormal proliferation of neoplastic lymphocytes – • S&S – localized or generalized lymphadenopathy ( cervical, axillary, inguinal & femoral), swelling is painless, nodes have gradually enlarged over months or years; can be diffuse s&s – B symptoms ( noc sweats, fever & wt loss, 1/3 have hepatomegaly or splenomegaly • Labs: CBC. ESR & peripheral smear,  LDH in advance stages, uric acid, Ca, • LN bx done for adenopathy > 3 weeks; B symptoms not attributed to other causes, abnormal blood tests, Xray– shows possible extranodular involvement, CT of abd & pelvis • Disease staging

  47. Non-Hodgkin’s Lymphoma • Medical Management – tx is based on classification of the cell & staging of ds. The ds process may be slow enough that tx is saved until ds takes a more aggressive path. • Stage 1-11 radiation alone may be curative • Intermediate-high grade lymphomas receive combo chemo; • combination chemo & radiation tx is done to produce tumor shrinkage & remission

  48. Nursing Management • History & Physical- • Any hx of HIV?, organ transplant, autoimmune ds, c/o painless enlarged LN? fever, noc sweats, wt loss, weakness & malaise, cough, dyspnea & chest pain (occur 20%  indicates lung involvement) • LN  palpate chains infraclavicular, iliac, femoral sites (involved nodes are painless, firm & rubbery in consistency)& abdomen signs of hepatosplenomegaly? & ascites? Skin lesions that look like nodules (20% of cases), • Psychosocial assessment – dx of cancer is devastating, more common in older adult, effects retirement plans  may lead to feelings of loss, grief, & anger.

  49. Oncology • Approx 1.2 – 1.3 million new cancers are dx each year • Over 500,000 cancer deaths/ yr • NCI = National Cancer Institute estimate 8.4 live today w a hx of cancer • Terminology: • Tumor – lump, mass, or swelling (lay public use as a synonym for cancer) • Neoplasm – (Greek neos = new, plasis = molding); abnormal mass of tissue serves no useful purpose & may harm the host organism • Benign – usually a harmless growth that does not spread or invade other tissues, does occupy space • Malignant – harmful mass, capable of invasion of other tissues & metastasis (spread) to distant organs • Cancer – used to refer to malignant neoplasms; ds of the cell in which normal mechanisms of control of growth & proliferation are altered, its invasive, spreads directly to surrounding tissue and to new sites • Oncology – refers to the medical specialty that deals w the dx, tx & study of cancer

  50. Oncology • Mortality rate = the # of deaths caused by cancer that occurs in a population in a given yr; expressed as # of deaths due to cancer per 100,000 persons. • Common misconceptions: • Cancer is one disease --- cancer is many diseases • The change from a normal cell to neoplastic cells is a process not a single event or a single alteration in cells; clinical manifestations are only the final stages in the natural history of cancer

More Related